Multiple Sclerosis (MS) Drug Market

FierceBiotech  Oct 17  Comment 
Merck KGaA returns PhII multiple sclerosis drug to Apitope ntaylor Mon, 10/17/2016 - 08:48
GenEng News  Oct 17  Comment 
Researchers have discovered that a protein in wheat triggers the inflammation in chronic health conditions, such as multiple sclerosis, asthma, and rheumatoid arthritis, and also contributes toward the development of nonceliac gluten...  Sep 29  Comment 
Actelion to investigate all-oral combination therapy for patients with relapsing multiple sclerosis Actelion Pharmaceuticals Ltd / Actelion to investigate all-oral combination therapy for patients with relapsing multiple sclerosis . Processed...
Motley Fool  Sep 28  Comment 
While Celgene looks to move into the MS space, Biogen isn't going down without a fight  Sep 16  Comment 
BERLIN (dpa-AFX) - Merck KGaA (MKGAY.PK) announced that it presented new efficacy data for investigational Cladribine Tablets in two oral presentations at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis...  Sep 14  Comment 
WESTON (dpa-AFX) - Biogen Inc. (BIIB) Wednesday said new real-world and clinical evidence demonstrates Tecfidera consistently delivered strong, sustained efficacy in newly-diagnosed and previously treated patients with relapsing-remitting multiple...
MarketWatch  Sep 14  Comment 
Biogen Inc. on Wednesday reported positive new data for its multiple sclerosis treatment Tecfidera in clinical and real-world settings. The biotech said the drug significantly reduced the time to a first relapse versus other treatments and...


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki